Recent studies have reported that IL-17A was involved in the early pathological process of AD, causing cognitive impairments and synaptic dysfunction (34) Neutralization of IL-17A restored the function of Aβ-induced neuroinflammation and memory impairment (35). The gene discussed is IL17A; the disease is Alzheimer disease.